Analystreport

Turning Point Therapeutics (NASDAQ: TPTX) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "sell" rating.

Turning Point Therapeutics, Inc. - Common stock  (TPTX) 
Last turning point therapeutics, inc. - common stock earnings: 3/16 09:00 am Check Earnings Report